This Biotech stock is likely to be a HUGE winner this year

A minimum expected target is 60% ROI ($6 per share). A multi-bagger is definitely in the cards as it historically returned several x from its previous bottoms in 2000 and 2008/2009.
Comment: Bullish structure still intact ... earnings release in two days. Technical structure continues to suggest major upside is more likely.

Comment: Major rally since yesterday

Comment: Massive failed breakout. I got lucky to get out at a small lose just under my average cost of 3.25. Situations like these should constantly remind us why risk management is so crucial to success as a trader.
Trade closed: stop reached: loss*
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out